Your browser doesn't support javascript.
loading
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).
Aglietta, Massimo; Chiarion-Sileni, Vanna; Fava, Paolo; Guidoboni, Massimo; Depenni, Roberta; Minisini, Alessandro; Consoli, Francesca; Ascierto, Paolo; Rinaldi, Gaetana; Banzi, Maria; Marconcini, Riccardo; Gueli, Rossana; Ferraresi, Virginia; Tucci, Marco; Tonini, Giuseppe; Lo Re, Giovanni; Guida, Michele; Del Vecchio, Michele; Marcon, Ilaria Gioia; Queirolo, Paola.
Afiliação
  • Aglietta M; Department of Oncology, University of Torino, Turin, Italy. massimo.aglietta@unito.it.
  • Chiarion-Sileni V; Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. massimo.aglietta@unito.it.
  • Fava P; Department of Clinical Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Guidoboni M; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Depenni R; Immunotherapy-Cell Therapy and Biobank, IRCCS-IRST, Meldola (FC), Italy.
  • Minisini A; Department of Oncology and Hematology, University Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Consoli F; Department of Oncology, Azienda Sanitaria Universitaria del Friuli Centrale, Udine, Italy.
  • Ascierto P; Department of Oncology, ASST Spedali Civili, Brescia, Italy.
  • Rinaldi G; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
  • Banzi M; UOC Oncologia Medica Aoup Paolo Giaccone, Palermo, Italy.
  • Marconcini R; Oncology Unit, Presidio Ospedaliero Arcispedale Santa Maria Nuova AUSL di Reggio Emilia-IRCCS, Reggio Emilia, Italy.
  • Gueli R; Presidio Ospedaliero S. Chiara-Az. Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Ferraresi V; Medical Oncology, ASST Sette Laghi, Circolo Hospital and Macchi Foundation, Varese, Italy.
  • Tucci M; Sarcomas and Rare Tumors Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
  • Tonini G; Department of Biomedical Sciences and Clinical Oncology, University of Bari, "Aldo Moro", Bari, Italy.
  • Lo Re G; Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy.
  • Guida M; Oncologia Medica e dei Tumori Immunocorrelati, CRO Aviano IRCCS, Aviano, Italy.
  • Del Vecchio M; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori "Giovanni Paolo II", Bari, Italy.
  • Marcon IG; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Queirolo P; Novartis Farma S.p.A, Origgio, Italy.
Target Oncol ; 16(6): 789-799, 2021 11.
Article em En | MEDLINE | ID: mdl-34755244
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Segunda Neoplasia Primária / Melanoma Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Segunda Neoplasia Primária / Melanoma Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália